Saturn V Capital Management LP
CIK 1964437 · Holdings on Jun 30, 2025 · First reported Aug 13, 2025
Top ten holdings
Q2 2025- JAZZ8.90%
- IRON8.50%
- AMLX8.47%
- PCVX7.17%
- COGT6.69%
- CELC6.41%
- CGON6.18%
- XENE5.94%
- DYN5.62%
- MLTX5.56%
Share classes counted separately69.44%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- ASNDWeight decreased · -13.00 pp15.67% → 2.67%Shares -161.07K (-80.83%)
- SNDXWeight decreased · -4.56 pp6.46% → 1.90%Shares -540.73K (-51.93%)
- IRONWeight decreased · -4.48 pp12.98% → 8.50%Shares -122.06K (-23.56%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 24
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | JAZZJAZZ PHARMACEUTICALS PLCSHS USD View history and evidence | $21.96M | 8.90% | 206.95K shares | Prior unavailable +206.95K | New | ↗▾ |
| 02 | IRONDISC MEDICINE INC View history and evidence | $20.98M | 8.50% | 396.12K shares | 12.98% → 8.50%-4.48 pp -122.06K (-23.56%) | Reduced | ↗▾ |
| 03 | AMLXAMYLYX PHARMACEUTICALS INC View history and evidence | $20.90M | 8.47% | 3.26M shares | 4.33% → 8.47%+4.14 pp +834.13K (+34.38%) | Added | ↗▾ |
| 04 | PCVXVAXCYTE INC View history and evidence | $17.69M | 7.17% | 544.22K shares | 4.43% → 7.17%+2.74 pp +311.93K (+134.28%) | Added | ↗▾ |
| 05 | COGTCOGENT BIOSCIENCES INC View history and evidence | $16.50M | 6.69% | 2.30M shares | 4.47% → 6.69%+2.22 pp +817.50K (+55.24%) | Added | ↗▾ |
| 06 | CELCCELCUITY INC View history and evidence | $15.83M | 6.41% | 1.19M shares | 5.58% → 6.41%+0.83 pp +91.84K (+8.40%) | Added | ↗▾ |
| 07 | CGONCG ONCOLOGY INC View history and evidence | $15.25M | 6.18% | 586.65K shares | 7.14% → 6.18%-0.96 pp +8.95K (+1.55%) | Added | ↗▾ |
| 08 | XENEXENON PHARMACEUTICALS INC View history and evidence | $14.66M | 5.94% | 468.36K shares | 7.00% → 5.94%-1.06 pp +54.65K (+13.21%) | Added | ↗▾ |
| 09 | DYNDYNE THERAPEUTICS INC View history and evidence | $13.86M | 5.62% | 1.46M shares | Prior unavailable +1.46M | New | ↗▾ |
| 10 | MLTXMOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD View history and evidence | $13.73M | 5.56% | 290.78K shares | 6.78% → 5.56%-1.22 pp -53.06K (-15.43%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 2
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| CRNX CRINETICS PHARMACEUTICALS IN | Non-derivative | -59,017 | -$1.98M | SEC filing ↗ | SEC filing ↗ |
| 45790W108 INOZYME PHARMA INC | Non-derivative | -499,254 | -$454.32K | SEC filing ↗ | SEC filing ↗ |
2 / 2 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1964437 · Period 2025-06-30
Data loaded 2026-09-23 · First reported 2025-08-13
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 246760882
}Take these holdings further.
This page includes 24 of 24 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 24 of 24 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1964437","quarter":"2025Q2","page_size":100}
get_institutional_manager_history
{"cik":"1964437","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.